advertisement

Oculus

11.6 Osmotic treatment (10)

Showing records 1 to 10

Display all abstracts in classification 11.6 Osmotic treatment

Search within classification 11.6 Osmotic treatment
80804 Effect of Mannitol on Intraocular Pressure in Vitrectomized and Nonvitrectomized Eyes: A Prospective Comparative Study
Ramachandra V
Journal of Glaucoma 2019; 28: 318-320
81351 Meibomian gland dropout rate as a method to assess meibomian gland morphologic changes during use of preservative-containing or preservative-free topical prostaglandin analogues
Lee SY
PLoS ONE 2019; 14: e0218886
80804 Effect of Mannitol on Intraocular Pressure in Vitrectomized and Nonvitrectomized Eyes: A Prospective Comparative Study
Chandran P
Journal of Glaucoma 2019; 28: 318-320
81351 Meibomian gland dropout rate as a method to assess meibomian gland morphologic changes during use of preservative-containing or preservative-free topical prostaglandin analogues
Lee K
PLoS ONE 2019; 14: e0218886
80804 Effect of Mannitol on Intraocular Pressure in Vitrectomized and Nonvitrectomized Eyes: A Prospective Comparative Study
Philip R; Philip R
Journal of Glaucoma 2019; 28: 318-320
81351 Meibomian gland dropout rate as a method to assess meibomian gland morphologic changes during use of preservative-containing or preservative-free topical prostaglandin analogues
Park CK
PLoS ONE 2019; 14: e0218886
80804 Effect of Mannitol on Intraocular Pressure in Vitrectomized and Nonvitrectomized Eyes: A Prospective Comparative Study
Arunaachalam V
Journal of Glaucoma 2019; 28: 318-320
81351 Meibomian gland dropout rate as a method to assess meibomian gland morphologic changes during use of preservative-containing or preservative-free topical prostaglandin analogues
Kim S; Bae HW
PLoS ONE 2019; 14: e0218886
80804 Effect of Mannitol on Intraocular Pressure in Vitrectomized and Nonvitrectomized Eyes: A Prospective Comparative Study
Raman GV
Journal of Glaucoma 2019; 28: 318-320
81351 Meibomian gland dropout rate as a method to assess meibomian gland morphologic changes during use of preservative-containing or preservative-free topical prostaglandin analogues
Seong GJ; Kim CY
PLoS ONE 2019; 14: e0218886

Issue 20-3

Select Issue


advertisement

WGW-2021